# New stomach cancer clinical trials, last 30 days: 31 (2026)

Updated November 19, 2026.

31 new trials for stomach cancer were first posted on ClinicalTrials.gov in the 30 days from October 20, 2026 to November 18, 2026, as read on November 19, 2026.

## The full list

New stomach cancer clinical trials, last 30 days: 31 rows for $5, first posted from October 20, 2026 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 5 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/new/stomach-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 31
- Recruiting or not yet: 26
- Read on: November 19, 2026

## Trials

The 25 newest of 31, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07945756 | Development of a Gastric Cancer Screening Intervention for H. Pylori Carriers Based on the Health Belief Model | Chinese University of Hong Kong | Not applicable | Not yet recruiting | Gastric Cancer (GC) | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945756) |
| November 18, 2026 | NCT07944664 | A Phase 4, Single-arm, Interventional Study to Evaluate the Safety and Tolerability of Zolbetuximab Plus SOX as First-line Treatment of... | Sponsor not shown (see the record) | Phase 4 | Active not recruiting | Gastric Cancer (GC), Gastroesophageal Junction (GEJ) Adenocarcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944664) |
| November 17, 2026 | NCT07943533 | HLX22 Combination Therapy in HER2-Positive Limited Metastatic Gastric Cancer | Shanghai Zhongshan Hospital | Phase 2 | Not yet recruiting | HER2-Positive, Limited Metastatic, Gastric Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943533) |
| November 16, 2026 | NCT07938021 | HLX22 Plus Serplulimab and Trastuzumab or Pertuzumab in HER2-Low Advanced Gastrointestinal Cancers | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 | Not yet recruiting | Gastric Cancer (Diagnosis), Colorectal Cancer (Diagnosis), Gastroesophageal Junction Cancer, Biliary Tract Cancer (BTC) | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938021) |
| November 12, 2026 | NCT07933471 | Total Neoadjuvant Immunotherapy Plus Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Beijing Tsinghua Chang Gung Hospital | Phase 2 | Recruiting | Gastric Cancer (GC), Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933471) |
| November 12, 2026 | NCT07932951 | Retrospective Analysis of a Psoralea Corylifolia (Buguzhi)-Containing TCM Formula for Gastrointestinal Cancers | Peking University Cancer Hospital & Institute | Observational | Active not recruiting | Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer (GC), Hepatocellular Carcinoma (HCC), Colorectal Cancer | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932951) |
| November 10, 2026 | NCT07928258 | A Study of LY4336619 in Adult Participants With Advanced Solid Tumors | Eli Lilly and Company | Phase 1 | Not yet recruiting | Endometrial Neoplasms, Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal, Carcinoma, Non-Small-Cell Lung, Stomach... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928258) |
| November 9, 2026 | NCT07924189 | Association of Psychological Distress With Clinical Outcomes in Patients With Digestive System Cancers | Xuanwu Hospital, Beijing | Observational | Active not recruiting | Psychological Distress, Pancreatic Cancer, Colorectal Cancer, Gastric Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924189) |
| November 6, 2026 | NCT07923396 | GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis | Ruijin Hospital | Phase 1 | Not yet recruiting | Gastric Cancer (GC) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923396) |
| November 6, 2026 | NCT07923214 | A Phase I Dose Escalation Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors | Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. | Phase 1 | Recruiting | Advanced Solid Tumors, Breast Cancer, Ovarian Cancer, Gastric Cancer, Other Solid Tumors | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923214) |
| November 6, 2026 | NCT07920705 | Nutritional Intervention After Total Gastrectomy for Gastric Cancer | Hanoi Medical University | Not applicable | Completed | Gastric Cancer (GC) | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920705) |
| November 5, 2026 | NCT07920224 | Candonilimab Combined With Fruquintinib and Paclitaxel Albumin-Bound as Second-Line Treatment for Advanced Gastric or Gastro-esophageal... | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 | Recruiting | Stomach Neoplasms | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920224) |
| November 5, 2026 | NCT07920068 | Epinephrine 1:100,000 Versus 1:500,000 During Gastric Endoscopic Submucosal Dissection | Sponsor not shown (see the record) | Not applicable | Recruiting | Gastric Neoplasms, Gastric Dysplasia | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920068) |
| November 3, 2026 | NCT07913165 | A Study of Trifluridine/Tipiracil (TAS-102) Combined With Nedaplatin for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma... | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Gastric Cancer (GC) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913165) |
| November 3, 2026 | NCT07912606 | D2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy for Gastric Cancer | The First Affiliated Hospital with Nanjing Medical University | Phase 2 | Not yet recruiting | Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912606) |
| November 2, 2026 | NCT07911280 | A Phase II, Trial of Neoadjuvant Trastuzumab + Durvalumab + FLOT Targeted Immunochemotherapy | Samsung Medical Center | Phase 2 | Recruiting | Gastric Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911280) |
| November 2, 2026 | NCT07911267 | Development and Utilization of an Integrated Clinical Genomic Database | Samsung Medical Center | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Lung Cancer (NSCLC), Liver Cancer, Pancreatic Cancer | 118,750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911267) |
| October 29, 2026 | NCT07904442 | Application of Intraperitoneal Hyperthermic Chemotherapy in the Treatment of Gastric Cancer With Peritoneal Metastasis | Anhui Provincial Cancer Hospital | Phase 2 | Not yet recruiting | Gastric Cancer (Diagnosis) | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904442) |
| October 29, 2026 | NCT07904260 | Effect of High-flow Nasal Cannula Oxygenation on the Incidence of Hypoxemia During Painless Gastrointestinal Endoscopy in Patients at High... | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Hypoxemia, Gastric Cancer (Diagnosis), Esophageal Cancer, High-altitude Illness, Obstructive Sleep Apnea (OSA) | 430 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904260) |
| October 29, 2026 | NCT07903857 | SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors | Guizhou Sinorda Pharmaceutical Co., Ltd. | Phase 1 | Not yet recruiting | Colorectal Neoplasms, Stomach Neoplasms, Solid Tumor Malignancies | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903857) |
| October 29, 2026 | NCT07903415 | A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. | Pfizer | Phase 1 | Recruiting | Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma... | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903415) |
| October 29, 2026 | NCT07902648 | Serplulimab, DOS and Lenvatinib Combine With PIPAC in the Oligometastatic Peritoneal Metastasis of Gastric/Gastroesophageal Junction... | Fujian Cancer Hospital | Phase 2 | Not yet recruiting | Gastric/Gastroesophageal Junction Adenocarcinoma, Oligometastatic Peritoneal Metastasis | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902648) |
| October 29, 2026 | NCT07902596 | Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma | The First Affiliated Hospital with Nanjing Medical University | Observational | Not yet recruiting | Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902596) |
| October 28, 2026 | NCT07899775 | Lymph Node Metastasis Pattern After Neoadjuvant Chemoimmunotherapy in LAGC | Hainan General Hospital | Observational | Not yet recruiting | Stomach Neoplasms, Gastric Cancer (Diagnosis), Gastric Adenocarcinoma | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899775) |
| October 27, 2026 | NCT07899697 | Feasibility Study of Middle Segmental Gastrectomy (MSG) for Gastric Cancer. | National Cancer Center, Korea | Not applicable | Active not recruiting | Gastric Cancer, Gastric Adenocarcinoma, Middle Segmental Gastrectomy (MSG), Function-preserving Surgery, Dumping... | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899697) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 2 |
| Phase 2 | 9 |
| Phase 4 | 1 |
| Not applicable | 8 |
| Observational | 6 |

## Sponsors posting most

| Sponsor | Trials |
| --- | --- |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| Samsung Medical Center | 2 |
| National Cancer Center, Korea | 2 |
| Chinese University of Hong Kong | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Peking University Cancer Hospital & Institute | 1 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 1 |
| Xuanwu Hospital, Beijing | 1 |
| Ruijin Hospital | 1 |
| Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. | 1 |
| Hanoi Medical University | 1 |
| Anhui Provincial Cancer Hospital | 1 |
| Guizhou Sinorda Pharmaceutical Co., Ltd. | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |
| Fujian Cancer Hospital | 1 |
| Hainan General Hospital | 1 |
| Medsyn Biopharma, LLC | 1 |
| The Affiliated Hospital of Qingdao University | 1 |
| [CSPC Megalith Biopharmaceutical Co.,Ltd.](https://specstream.ai/data/clinical-trials/company/cspc-megalith-biopharmaceutical-co-ltd) | 1 |
| Centre Leon Berard | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Music schools in the United States](https://specstream.ai/data/businesses/music-schools/united-states)
- [Public relations firms in the United States](https://specstream.ai/data/businesses/public-relations-firms/united-states)
- [Tenant and eviction law firms in the United States](https://specstream.ai/data/businesses/tenant-and-eviction-law-firms/united-states)
- [Anesthesiology practices in the United States](https://specstream.ai/data/businesses/anesthesiology-practices/united-states)
- [Burmese restaurants in the United States](https://specstream.ai/data/businesses/burmese-restaurants/united-states)
- [Doner kebab restaurants in the United States](https://specstream.ai/data/businesses/doner-kebab-restaurants/united-states)
